Efficacy and safety of immunotherapy combined with single-agent chemotherapy as second- or later-line therapy for metastatic non-small cell lung cancer

Efficacy and safety of immunotherapy combined with single-agent chemotherapy as second- or later-line therapy for metastatic non-small cell lung cancer

ObjectiveThis study sought to assess the efficacy and safety of immunotherapy combined with single-agent chemotherapy as a second- or later-line setting for metastatic non-small cell lung cancer (NSCLC) and to provide clinical evidence for this treatment regimen. The predictive value of extracellula...

Full description

Bibliographic Details
Main Authors: Dongna Chen, Lin Li, Mingzhao Wang, Xingsheng Hu, Jun Jiang, Weihua Li, Lin Yang, Meng Fan, Yuankai Shi, Fang Lv, Yutao Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-09-01
Series:Frontiers in Immunology
Subjects:
non-small cell lung cancer
immunotherapy
chemotherapy
EV markers
EGFR
VEGFR2
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1086479/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1086479/full

Similar Items